The composition and magnitude of CD3+ and CD8+ T cells have been linked to a prognostic significance in patients affected by CRC, leading to the successful introduction of an Immunoscore to further generate detailed and personalized patient prognostic information25. This evidence concerns the gene CD8A and colorectal carcinoma.